40 results
424B5
COGT
Cogent Biosciences Inc
30 Nov 20
Prospectus supplement for primary offering
5:28pm
the European Union, extensively regulate, among other things, the research, development, testing, product approval, manufacture, quality control … and Approval of Drug Products in the European Union
In order to market any pharmaceutical product outside of the United States, a company must also
424B5
COGT
Cogent Biosciences Inc
2 Dec 20
Prospectus supplement for primary offering
5:06pm
in the United States, at the federal, state and local levels, and in other countries and jurisdictions, including the European Union, extensively regulate … in the European Union
In order to market any pharmaceutical product outside of the United States, a company must also comply with numerous and varying regulatory
8-K
EX-99.1
6rx6d
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
10-K
b0d2sufp
28 Mar 19
Annual report
7:31am
DEFM14A
2gcjgu80
9 Oct 20
Proxy related to merger
4:44pm
8-K
EX-1.1
xycqlj
2 Dec 20
Entry into a Material Definitive Agreement
5:08pm
S-3
EX-1.2
dwngh
2 Apr 19
Shelf registration
12:00am
8-K
EX-10.1
5c6k6uukwbvr 57yvm7
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-1.1
1b8pkhtoauad6re
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm